both diflunisal ( 750 mg/day ) and ibuprofen ( 1600 mg/day ) were shown to be superior to placebo in the treatment of rheumatoid arthritis in a double-blind cross-over trial .
C0020740
ibuprofen
C0003873
rheumatoid arthritis